… In a phase II study in patients with metastatic melanoma, … plus pegylated interferonalpha-2b
for metastatic … the response rates of carmustine, dacarbazine, and cisplatin with and without …

… A phase II trial (n = 28) assessed the response of melanoma patients … tamoxifen in combination
with chemotherapy (carmustine, dacarbazine, cisplatin, interferon-alpha 2b, interleukin-2) …

… studies utilize dacarbazine adjunct to other agents using the Dartmouth regimen which includes
carmustine, tamoxifen, and cisplatin… aDC1) vaccine, interferon alpha-2, rintatolimod, and …

… regimen (dacarbazine, cisplatin, carmustine, and tamoxifen) … and interferon-alpha agents,
among others. Although patients … However, the lack of phase II efforts in these treatment …

… cisplatin, dacarbazine, carmustine, and tamoxifen originally reported in a phase III randomized
clinical trial … antibody treatment, which is currently undergoing phase II clinical trial as an …

… for lung metastasis from malignant melanoma in the … of cisplatin, dacarbazine, carmustine
and tamoxifen) were extensively studied, but did not yield a survival benefit over dacarbazine …

… , stage two is also a localized form but with a high risk of … 2 which stimulates T cell proliferation
and Interferon alpha; the … of dacarbazine, carmustine, cisplatin, and tamoxifen and the …

… dacarbazine given alone or in combination with other chemotherapeutic agents or biological
modifiers such as cisplatin, vinblastine, vindesine, carmustine… as IL-2 or interferon-alpha 2B. …

… (cisplatin, vinblastine or vindesine, and dacarbazine) and Dartmouth (carmustine, dacarbazine,
cisplatin, and tamoxifen… first-line therapy for stage II melanoma patients in 1998 based on …

… A multicenter Italian study compared cisplatin plus dacarbazine plus optional carmustine
versus the same … with interferon alpha-2b and tamoxifen in patients with metastatic …